mots-c
Elevated Serum Nardilysin Is Inversely Associated with Cardiovascular Disease in Kidney Transplant Recipients.
PubMed · Publication · 2026-05-21T00:00:00
Research Summary
Kidney transplant recipients (KTRs) suffer from enhanced cardiovascular (CV) and metabolic burden due to interplay between pro-inflammatory and metabolic risk factors.
Nardilysin (NRDc) and mitochondrial open reading frame of 12S rRNA-c (MOTS-c) are circulating peptides that represent candidate markers of cardiometabolic pathobiology, though their relevance in KTRs is unknown.
We measured serum NRDc and MOTS-c concentrations in an observational cohort of 150 patients (118 KTRs and aged-matched controls-32 patients) using commercial ELISA kits.
KTRs were followed for a median of 29.2 (25.3-31.9) months.
Relationships with CV and metabolic parameters were assessed using Pearson's correlation and penalized logistic regression.
Renal allograft loss with all-cause mortality as competing event was examined using Fine-Gray regression.
Median serum NRDc (1.91 vs.
0.42 ng/mL, P<0.001) and MOTS-c (178 vs.
142 ng/mL, P=0.014) were significantly higher in KTRs, as compared with controls.
NRDc showed a weak positive linear relationship with body-mass index (r=0.21, P=0.02).
After adjusting for age and sex, higher standardized ln-NRDc was independently associated with lower odds of prevalent CV disease (OR 0.59, 95% CI 0.34-0.97, P=0.04).
This CV disease association was stable after further adjustment for hsIL-6.
We did not observed significant associations for MOTS-c and cardiometabolic features.
In competing risks analysis, MOTS-c showed a consistent but non-significant trend toward lower risk of allograft loss (adj.
sHR 0.50, 95% CI 0.22-1.10, P=0.08), while NRDc was not associated with allograft loss.
Both serum NRDc and MOTS-c marker were not associated with all-cause mortality or follow-up eGFR decline.
Elevated circulating serum NRDc and MOTS-c levels in KTRs may reflect altered metabolic and inflammatory pathways.
The inverse association between NRDc and prevalent CV disease warrants further investigation in longitudinal studies with incident CV events..
Paper Metadata
Compound: mots-c
Journal: Kidney & blood pressure research
Source: PubMed
Type: Publication
Published: 2026 May 21
PubMed ID: 42166398
Authors
Sączek A, Batko K, Banaszkiewicz M, Małyszko J, Koc-Żórawska E, Żórawski M, Niezabitowska K, Sobczyńska K, Miarka P, Bętkowska-Prokop A, Krzanowska K, Krzanowski M
Research Radar Analysis
AI analysis has not been generated for this paper yet.